Virtu Financial LLC Inmune Bio, Inc. Transaction History

Virtu Financial LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 17, 2022	SELL	$6.42 - $11.39 $156,416 - $277,505	-24,364 Closed	0 $0
Q4 2021 Feb 17, 2022	BUY	$9.97 - $20.38 $242,909 - $496,538	24,364 New	24,364 $249,000
Q3 2021 Nov 12, 2021	SELL	$14.13 - $27.85 $148,788 - $293,260	-10,530 Closed	0 $0
Q2 2021 Sep 17, 2021	BUY	$9.29 - $19.33 $97,823 - $203,544	10,530 New	10,530 $185,000

5.88M

243K

46.4K

Ticker INMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,946,000
Market Cap $89M
Description
INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on tr...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.